Molecular Partners AG
MOLN
$3.77
-$0.20-5.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 42.74% | -46.43% | 6.22% | 18.89% | -23.36% |
| Total Depreciation and Amortization | 26.54% | -0.09% | -0.76% | 4.98% | 12.32% |
| Total Amortization of Deferred Charges | -37.51% | -- | -- | -- | 6.18% |
| Total Other Non-Cash Items | -183.94% | 414.82% | -75.12% | -330.71% | 26.48% |
| Change in Net Operating Assets | 194.06% | 62.09% | -380.43% | 25.75% | -8.26% |
| Cash from Operations | 16.78% | -2.81% | -17.67% | -9.07% | -21.82% |
| Capital Expenditure | 53.97% | -185.12% | -57.38% | -98.72% | 42.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.24% | -17.26% | 219.12% | 446.37% | -41.12% |
| Cash from Investing | -123.29% | -18.30% | 223.94% | 453.07% | -41.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00% | -0.67% | -1.00% | -0.67% | -0.67% |
| Issuance of Common Stock | 867,150.00% | -50.00% | 40.00% | -50.00% | -33.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,277.89% | -3.14% | 3.12% | -6.88% | -8.69% |
| Foreign Exchange rate Adjustments | 112.06% | -166.87% | 115.42% | 250.29% | -49.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.72% | -98.69% | 75.27% | 107.82% | -106.49% |